Oligonucleotide Synthesis Market worth 1,918.6 Million USD by 2020 - PowerPoint PPT Presentation

About This Presentation

Oligonucleotide Synthesis Market worth 1,918.6 Million USD by 2020


Oligonucleotide Synthesis Market worth 1,918.6 Million USD by 2020 – PowerPoint PPT presentation

Number of Views:22


Transcript and Presenter's Notes

Title: Oligonucleotide Synthesis Market worth 1,918.6 Million USD by 2020

MarketsandMarkets Presents
  • Oligonucleotide Synthesis Market- Global Forecast
    to 2019

  • The global oligonucleotide synthesis market is
    expected to reach 1,712.1 million by 2019 from
    1,070.7 million in 2014, growing at a CAGR of
    9.8 from 2014 to 2019. Factors driving market
    growth include growing RD expenditure in
    pharmaceutical and biotech companies, emerging
    applications in molecular diagnostics and
    synthetic biology, and the evolving significance
    of RNA-interference oligos in therapeutics and
    diagnostics. However, regulatory barriers,
    especially for therapeutic oligos, and downward
    pricing pressure are the major factors
    restraining the growth of this market.
  • North America dominates the oligonucleotide
    synthesis market, with the U.S. accounting for
    the major market share. Asia-Pacific is poised to
    grow at the highest CAGR during the forecast
    period, owing to increasing RD activities and
    funding, and the growing availability of
    synthesized oligos in this region. 

  • http//www.marketsandmarkets.com/Market-Reports/ol
  • Prominent players in the market are Agilent
    Technologies, Inc. (U.S.), BioAutomation
    Corporation (U.S.), BioSearch Technologies, Inc.
    (U.S.), Eurofins Genomics (Germany), Eurogentec
    (Belgium), GE Healthcare (U.K.), Glen Research
    (U.S.), Gene Link, Inc. (U.S.), GenScript USA
    Inc. (U.S.), GeneDesign, Inc. (Japan), Integrated
    DNA Technologies, Inc. (IDT) (U.S.), Link
    Technologies, Ltd. (U.K.), Nitto Denko Avecia,
    Inc. (U.S.), Sigma-Aldrich Co. LLC. (U.S.),
    Thermo Fisher Scientific, Inc. (U.S.), and
    TriLink BioTechnologies, Inc. (U.S.).

  • The market, by applications, is classified into
    diagnostics, research, and therapeutics. Research
    applications are further segmented into PCR,
    qPCR, sequencing, gene synthesis, and others. The
    therapeutics market is further segmented into
    DNA/antisense oligos, RNAi, aptamers, and others.
    In terms of applications, the research segment
    commanded the largest share in 2014, while the
    diagnostics segment is expected to be the
    fastest-growing segment in the oligonucleotide
    synthesis market. The therapeutics segment is
    gaining increasing importance with growing RNAi
    applications. However, stringent regulatory
    requirements pose a major challenge for this

Contact Us
  • Mr. RohanMarkets and Markets UNIT no 802, Tower
    no. 7, SEZMagarpatta city, HadapsarPune,
    Maharashtra 411013, India1-888-600-6441Email
  • MarketsandMarkets Blog
  • http//www.linkedin.com/company/marketsandmarkets
  • http//twitter.com/marketsmarkets

About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
Write a Comment
User Comments (0)
About PowerShow.com